<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To estimate the likely number and predictive strength of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-associated single nucleotide polymorphisms (SNPs) that are yet to be discovered for seven common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: From the statistical power of published genome-wide association studies, we estimated the number of undetected susceptibility loci and the distribution of effect sizes for <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Assuming a log-<z:mpath ids='MPATH_458'>normal</z:mpath> model for risks and multiplicative relative risks for SNPs, family history (FH), and known risk factors, we estimated the area under the receiver operating characteristic curve (AUC) and the proportion of patients with risks above risk thresholds for screening </plain></SENT>
<SENT sid="3" pm="."><plain>From additional prevalence data, we estimated the positive predictive value and the ratio of non-patient cases to patient cases (false-positive ratio) for various risk thresholds </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Age-specific discriminatory accuracy (AUC) for models including FH and foreseeable SNPs ranged from 0.575 for <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">ovarian cancer</z:e> to 0.694 for <z:hpo ids='HP_0012125'>prostate cancer</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The proportions of patients in the highest decile of population risk ranged from 16.2% for <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">ovarian cancer</z:e> to 29.4% for <z:hpo ids='HP_0012125'>prostate cancer</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The corresponding false-positive ratios were 241 for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, 610 for <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">ovarian cancer</z:e>, and 138 or 280 for <z:hpo ids='HP_0003002'>breast cancer</z:hpo> in women age 50 to 54 or 40 to 44 years, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Foreseeable common SNP discoveries may not permit identification of small subsets of patients that contain most <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Usefulness of screening could be diminished by many false positives </plain></SENT>
<SENT sid="9" pm="."><plain>Additional strong risk factors are needed to improve risk discrimination </plain></SENT>
</text></document>